ESC 365 - New frontiers in the management of amyloid heart disease.

HFA Premium Access

New frontiers in the management of amyloid heart disease.

Session: Optimal therapeutic approach in cardiomyopathies

Topic: Myocardial Disease

Speaker: Professor C. Rapezzi (Ferrara, IT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)

29 presentations

3 followers

4 more presentations in this session

Etiology-based and device treatment in dilated cardiomyopathy.

Speaker: Professor P. Seferovic (Belgrade, RS)

Novel treatments in hypertrophic cardiomyopathy

Speaker: Professor M. Tome Esteban (London, GB)

Genetic-phenotype therapeutic approach in arrhythmogenic right ventricular cardiomyopathy.

Speaker: Professor E. Behr (London, GB)

Optimal therapeutic approach in cardiomyopathies - discussion.

Access the full session

Optimal therapeutic approach in cardiomyopathies

Speakers: Professor C. Rapezzi, Professor P. Seferovic, Professor M. Tome Esteban, Professor E. Behr

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources